Latest Posts

Broker’s call: Aurobindo Pharma (Buy)

Target: ₹1,360 CMP: ₹1,206 Aurobindo Pharma (ARBP) is actively investing across multiple high-potential segments to drive sustained growth over the next 3-5 years. The company’s Penicillin G (PEN-G) project is scaling up meaningfully, effectively curbing operational losses, and is expected to contribute materially to profitability in FY26 and FY27. In the US generics market, ARBP continues...
Read more

Zinc futures: Bulls banking on a base

The price of zinc futures has largely been range-bound over the past month. Last week, it rebounded off a support and closed at ₹251/kg on Friday. But as it stands, the price band of ₹244-256, within which it has been oscillating over the past month, remains valid. Ideally, zinc futures ought to move out of...
Read more

MAN Industries Q4 profit surges 182% to ₹68.1 crore

MAN Industries (India) Ltd announced its highest-ever quarterly and annual performance in financial results released Monday. The pipe manufacturer posted a consolidated profit after tax of ₹68.1 crore for Q4FY25, representing a 182.4 per cent increase compared to the same period last year. The company’s Q4 consolidated revenue grew by 50.3 per cent year-on-year to...
Read more

Returns from factor-based investing can be more volatile due to higher retail participation

Factor-based investing is an approach that is catching on among Indian investors. Better awareness among investors, increased regulatory support and data availability are driving this transition in India. Compared with developed markets, momentum and quality have shown relatively strong persistence in India, especially during trending or earnings-driven markets, according to Bhavesh Jain, Co-Head – Factor...
Read more
1 10 11 12 13 14 201

Trending News

Editor's Picks

Startup Battlefield 200 applications close at midnight

These are your final hours to apply to the most iconic pitch competition in tech — Startup Battlefield 200. Battle it out in front of 10,000+ startup leaders, investors, and media at TechCrunch Disrupt 2025. It’s your moment to be seen, funded, and remembered — and maybe even walk away with $100,000 in equity-free funding....

The investor experience at TC All Stage

TechCrunch All Stage isn’t a waiting room for warm intros — it’s a floor full of founders, ideas, and breakout potential. For VCs, it’s a rare chance to skip the filters and meet the future of tech in one place, on one day, with no layers between you and the next standout story. Whether you’re...

ALL INDIA MSMES PROMOTION AND WELFARE ASSOCIATION

Quick Links

Popular Categories

Must Read

AIMPWA © 2025- All Right Reserved. Designed and Developed by  growGX.com